Results 221 to 230 of about 1,694,268 (297)

Psychometric Properties of the Choosing Wisely Questions in a Large Psychiatric Sample. [PDF]

Int J Methods Psychiatr Res
Bengtsson J, Andersson A, Forss Lilja N, Hultgren Farsani I, Lissbrant E, Wettermark B, Blomqvist I.   +6 more
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Predictors and prescribing patterns of definite anticholinergic medication use among community-dwelling older adults in Saudi Arabia: a retrospective multicenter cross-sectional study. [PDF]

Front Med (Lausanne)
Alamer KA, Albekery MA, Keshk N, Alotaibi FM, Alhomoud IS, Alwadai AH, Alotaibi MM, Almuslim AM, Nasfan AH, Aldukhi MA, Aldossary T, AlMosyab N, Alnaim KS, Alnaim WA, Alharbi YA, Shabib MY, Alhulibi RM, Alayesh NA.   +17 more
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Molecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu, Nicolas J. Niklaus, Anna M. Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof‐de Julio, Inti Zlobec, Jörn Dengjel, Bruce E. Torbett, Mario P. Tschan   +13 more
wiley   +1 more source

Supporting Medication Adherence in Parkinson's Through Education: A Scoping Review of Interventions. [PDF]

Health Expect
Haworth H, Carter G, Rogers KMA, Mitchell G, Jacobs L, Stark P.   +5 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Medical libraries and medical education

Academic Medicine, 1966
openaire   +3 more sources

In-hospital medication administration prior to in-hospital cardiac arrest: a matched case-control study. [PDF]

Resusc Plus
Hansen SH, Lind PC, Hansen FG, Stankovic N, Holmberg MJ, Andersen LW, Granfeldt A.   +6 more
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source